Differential expression of adenylyl cyclase subtypes in human cardiovascular system.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  2004-08-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MCE.2004.05.012PMID 15279911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No Abstract Available

  2005cited by this paper
• Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies.

  2002cited by this paper
• New determinants of receptor-effector coupling: trafficking and compartmentation in membrane microdomains.

  2002cited by this paper
• Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems.

  2002cited by this paper
• Influence of β1-adrenoceptor blockade on the gene expression of adenylate cyclase subtypes and β-adrenoceptor kinase in human atrium

  2001cited by this paper
• Influence of beta1-adrenoceptor blockade on the gene expression of adenylate cyclase subtypes and beta-adrenoceptor kinase in human atrium.

  2001cited by this paper
• Receptor Number and Caveolar Co-localization Determine Receptor Coupling Efficiency to Adenylyl Cyclase*

  2001cited by this paper
• mRNA quantification by real time TaqMan polymerase chain reaction: validation and comparison with RNase protection.

  1999cited by this paper
• Specific activation of adenylyl cyclase V by a purinergic agonist

  1998cited by this paper
• Inhibition of adenylyl cyclase isoforms V and VI by various Gbetagamma subunits.

  1998cited by this paper
• Inhibition of adenylyl cyclase isoforms V and VI by various Gβγ subunits

  1998cited by this paper
• Regulation of adenylyl cyclase type V/VI in smooth muscle: interplay of inhibitory G protein and Ca2+ influx.

  1998cited by this paper
• Evidence for the shuttle model for GSα activation of adenylyl cyclase

  1997cited by this paper
• The adenylyl cyclases as integrators of transmembrane signal transduction.

  1997cited by this paper
• Evidence for the shuttle model for Gs alpha activation of adenylyl cyclase.

  1997cited by this paper
• Examination of the effects of increasing Gs protein on beta2-adrenergic receptor, Gs, and adenylyl cyclase interactions.

  1997cited by this paper
• Myocardial adenylyl cyclase type V and VI mRNA: differential regulation with age.

  1996cited by this paper
• Adenylyl cyclase isoforms are differentially expressed in primary cultures of endothelial cells and whole tissue homogenates from various rat tissues.

  1995cited by this paper
• Determination and cellular localization of adenylyl cyclase isozymes expressed in embryonic chick heart

  1995cited by this paper
• Type V, but not type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development. Correlation with increased global adenylyl cyclase activity.

  1995cited by this paper
• Purification of Recombinant G Proteins from Sf9 Cells by Hexahistidine Tagging of Associated Subunits

  1995cited by this paper
• Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs.

  1994cited by this paper
• Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle.

  1994cited by this paper
• Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells.

  1994cited by this paper
• Molecular and functional diversity of mammalian Gs‐stimulated adenylyl cyclases

  1993cited by this paper
• Isolation and characterization of a novel cardiac adenylylcyclase cDNA.

  1992cited by this paper
• Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family.

  1992cited by this paper
• Cloning and expression of a widely distributed (type IV) adenylyl cyclase.

  1991cited by this paper
• Sequence of a human brain adenylyl cyclase partial cDNA: evidence for a consensus cyclase specific domain.

  1991cited by this paper
• A 5-HT4-like receptor in human right atrium

  1991cited by this paper
• A comparison of the effects of adrenaline and noradrenaline on human heart: the role of beta 1- and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force.

  1989cited by this paper

• Adenylyl cyclase isoforms 5 and 6 in the cardiovascular system: complex regulation and divergent roles

  2024cites this paper
• Nanodomain cAMP signalling in cardiac pathophysiology: potential for developing targeted therapeutic interventions.

  2024cites this paper
• Preferential Expression of Ca2+-Stimulable Adenylyl Cyclase III in the Supraventricular Area, including Arrhythmogenic Pulmonary Vein of the Rat Heart

  2022cites this paper
• Physiological Roles of Mammalian Transmembrane Adenylyl Cyclase Isoforms.

  2021cites this paper
• Elevated Vasodilatory Cyclases and Shorter Telomere Length Contribute to High-Altitude Pulmonary Edema

  2018cites this paper
• International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases

  2017influential citation
• Isoform Selective Regulation of Adenylyl Cyclase by Small Molecule Inhibitors and Gbetagamma Protein

  2015cites this paper
• Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases.

  2014cites this paper
• Adenylyl cyclase regulation in heart failure due to myocardial infarction in rats

  2014cites this paper
• Similarly Potent Inhibition of Adenylyl Cyclase by P-Site Inhibitors in Hearts from Wild Type and AC5 Knockout Mice

  2013cites this paper
• The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.

  2013cites this paper
• Role of adenylyl cyclase S674 in central and forearm vasomotor control

  2013cites this paper
• CHARACTERIZATION OF SELECTIVE INHIBITION OF ADENYLYL CYCLASE ACTIVITY BY SMALL MOLECULE INHIBITOR NKY80

  2012cites this paper
• Effect of the Arg389Gly β1‐adrenoceptor polymorphism on plasma renin activity and heart rate, and the genotype‐dependent response to metoprolol treatment

  2012cites this paper
• Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch–Nyhan disease: BODIPY–forskolin as pharmacological tool

  2012cites this paper
• Inhibitors of membranous adenylyl cyclases.

  2012cites this paper
• Identification of novel drug targets for the treatment of heart failure

  2012cites this paper
• Choreographing the adenylyl cyclase signalosome: sorting out the partners and the steps

  2011cites this paper
• Regulation of renin release by local and systemic factors.

  2011cites this paper
• Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications.

  2011cites this paper
• Atrial and Vascular Oxidative Stress in Patients with Heart Failure

  2011cites this paper
• Stimulation of Renin Secretion by Catecholamines Is Dependent on Adenylyl Cyclases 5 and 6

  2011cites this paper
• Physiology of kidney renin.

  2010cites this paper
• Impaired water reabsorption in mice deficient in the type VI adenylyl cyclase (AC6)

  2010cites this paper
• Increased Blood Pressure and Hyperdynamic Cardiovascular Responses in Carriers of a Common Hyperfunctional Variant of Adenylyl Cyclase 6

  2010cites this paper
• Adenylyl cyclase type 5 protein expression during cardiac development and stress.

  2009cites this paper
• Chronic Lymphocytic Leukemia and B and T Cells Differ in Their Response to Cyclic Nucleotide Phosphodiesterase Inhibitors1

  2009cites this paper
• New Signaling Pathways Associated with Increased Cardiac Adenylyl Cyclase 6 Expression: Implications for Possible CHF Therapy

  2008cites this paper
• New insights into the regulation of cAMP synthesis beyond GPCR/G protein activation: implications in cardiovascular regulation.

  2007cites this paper
• Regulation of Cardiac cAMP Synthesis and Contractility by Nucleoside Diphosphate Kinase B/G Protein &bgr;&ggr; Dimer Complexes

  2007cites this paper
• New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy.

  2007cites this paper
• Cardiac GPCRs: GPCR signaling in healthy and failing hearts.

  2007cites this paper
• Regulation of Cardiac cAMP Synthesis and Contractility by Nucleoside Diphosphate Kinase B/G Protein (cid:1)(cid:2) Dimer Complexes

  2007cites this paper
• Increased Enzyme Activity and &bgr;-Adrenergic–Mediated Vasodilation in Subjects Expressing a Single-Nucleotide Variant of Human Adenylyl Cyclase 6

  2007cites this paper
• Renin: friend or foe?

  2007cites this paper
• Compartmentation of cAMP signaling in cardiac myocytes: a computational study.

  2007cites this paper
• The Calcium Paradoxon of Renin Release: Calcium Suppresses Renin Exocytosis by Inhibition of Calcium-Dependent Adenylate Cyclases AC5 and AC6

  2006cites this paper
• Adenylyl Cyclase 6 Overexpression Decreases the Permeability of Endothelial Monolayers via Preferential Enhancement of Prostacyclin Receptor Function

  2006cites this paper
• Adenylyl Cyclase Isoform–Selective Regulation of Vascular Smooth Muscle Proliferation and Cytoskeletal Reorganization

  2006cites this paper